Recursos empleados en el tratamiento de la enfermedad de Crohn perianal y sus resultados en una serie de vida real

Sandborn, 2003, AGA technical review on perianal Crohn's disease, Gastroenterology., 125, 1508, 10.1016/j.gastro.2003.08.025

Satsangi, 2006, The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications, Gut., 55, 749, 10.1136/gut.2005.082909

Gionchetti, 2017, 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical management and special situations, J Crohns Colitis., 11, 135, 10.1093/ecco-jcc/jjw169

Siddiqui, 2012, A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment, Dis Colon Rectum., 55, 576, 10.1097/DCR.0b013e318249d26c

Schwartz, 2001, A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas, Gastroenterology., 121, 1064, 10.1053/gast.2001.28676

Khan, 2011, Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis, Am J Gastroenterol., 106, 661, 10.1038/ajg.2011.72

Aguilera-Castro, 2017, Management of complex perianal Crohn's disease, Ann Gastroenterol., 30, 33

West, 2004, Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: A double-blind placebo-controlled study, Aliment Pharmacol Ther, 20, 1329, 10.1111/j.1365-2036.2004.02247.x

Dewint, 2014, Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: A randomised, double-blind, placebo controlled trial (ADAFI), Gut, 63, 292, 10.1136/gutjnl-2013-304488

Pearson, 1995, Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis, Ann Intern Med., 123, 132, 10.7326/0003-4819-123-2-199507150-00009

Van Assche, 2010, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations, J Crohns Colitis., 4, 63, 10.1016/j.crohns.2009.09.009

Lichtiger, 2010, The CHOICE trial: Adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy, Aliment Pharmacol Ther., 32, 1228, 10.1111/j.1365-2036.2010.04466.x

Schreiber, 2011, Randomised clinical trial: Certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study, Aliment Pharmacol Ther., 33, 185, 10.1111/j.1365-2036.2010.04509.x

De Groof, 2016, Treatment of perianal fistula in Crohn's disease: A systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment, Colorectal Disease., 18, 667, 10.1111/codi.13311

Hyder, 2006, Fistulating anal Crohn's disease: Results of combined surgical and infliximab treatment, Dis Colon Rectum., 49, 1837, 10.1007/s10350-006-0656-5

Feagan, 2015, Vedolizumab for the treatment of fistulizing Crohn's disease: An exploratory analysis of data from GEMINI 2, J Crohns Collitis., 9, S333, 10.1093/ecco-jcc/jju027.626

Feagan, 2016, Ustekinumab as induction and maintenance therapy for Crohn's disease, N Engl J Med., 375, 1946, 10.1056/NEJMoa1602773

Khorrami, 2016, Ustekinumab for the treatment of refractory Crohn's disease: The Spanish experience in a large multicentre open-label cohort, Inflamm Bowel Dis., 22, 1662, 10.1097/MIB.0000000000000842

Bermejo, 2017, Pharmacological approach to the management of Crohn's disease patients with perianal disease, Drugs., 78, 1, 10.1007/s40265-017-0842-x

Panés, 2017, Perianal fistulizing Crohn's disease: Pathogenesis, diagnosis and therapy, Nat Rev Gastroenterol Hepatol., 14, 652, 10.1038/nrgastro.2017.104

Thia, 2009, Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study, Inflamm Bowel Dis, 15, 17, 10.1002/ibd.20608

Sands, 2004, Long-term treatment of rectovaginal fistulas in Crohn's disease: Response to infliximab in the ACCENT II Study, Clin Gastroenterol Hepatol., 2, 912, 10.1016/S1542-3565(04)00414-8

Colombel, 2009, Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: Results from the CHARM trial, Am J Gastroenterol., 104, 1170, 10.1038/ajg.2009.59

Sandborn, 2013, Vedolizumab as induction and maintenance therapy for Crohn's disease, N Engl J Med., 369, 711, 10.1056/NEJMoa1215739

Sands, 2017, Fistula healing in pivotal studies of ustekinumab in Crohn's disease, Gastroenterology., 152, S185, 10.1016/S0016-5085(17)30930-7